Atrium Research analyst initiated coverage with a Buy rating on Rubicon Organics today and set a price target of C$1.00. The company’s shares closed yesterday at $0.40.
Elevate Your Investing Strategy:
- Take advantage of TipRanks Premium at 50% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence.
Rubicon Organics has an analyst consensus of Moderate Buy, with a price target consensus of $0.66.
ROMJF market cap is currently $26.8M and has a P/E ratio of 190.48.
Read More on ROMJF:
Disclaimer & DisclosureReport an Issue
- Rubicon Organics to Showcase at Key Investor Events and Engages Research Firm
- Rubicon Organics Shines in Q2 2025 Earnings Call
- Rubicon Organics Reports Strong Q2 2025 Growth
- Rubicon Organics: Strong Q2 Performance and Strategic Growth Justify Buy Rating
- Rubicon Organics Achieves Record Q2 2025 Revenue and Expands Capacity
This article contains syndicated content. We have not reviewed, approved, or endorsed the content, and may receive compensation for placement of the content on this site. For more information please view the Barchart Disclosure Policy here.
/A%20concept%20image%20of%20space_%20Image%20by%20Canities%20via%20Shutterstock_.jpg)
/A%20concept%20image%20of%20a%20flying%20car_%20Image%20by%20Phonlamai%20Photo%20via%20Shutterstock_.jpg)
/Oracle%20Corp_%20office%20logo-by%20Mesut%20Dogan%20via%20iStock.jpg)